Subjects: H.R.5651 — 112th Congress (2011-2012)

  • Administrative law and regulatory procedures
  • Administrative remedies
  • Advisory bodies
  • Business records
  • Cancer
  • Child health
  • Congressional oversight
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Food and Drug Administration (FDA)
  • Fraud offenses and financial crimes
  • Genetics
  • Government employee pay, benefits, personnel management
  • Government information and archives
  • Health
  • Health care coverage and access
  • Health care quality
  • Health information and medical records
  • Health programs administration and funding
  • Health technology, devices, supplies
  • Infectious and parasitic diseases
  • Intellectual property
  • Jurisdiction and venue
  • Licensing and registrations
  • Manufacturing
  • Medical research
  • Medical tests and diagnostic methods
  • Prescription drugs
  • Product safety and quality
  • Public-private cooperation
  • Research administration and funding
  • Research and development
  • Small business
  • Trade agreements and negotiations
  • Trade restrictions
  • Trade secrets and economic espionage
  • User charges and fees